First Foundation Advisors Amgen Inc Transaction History

First Foundation Advisors

$2.56 Billion
Q2 2024

A detailed history of First Foundation Advisors transactions in Amgen Inc stock. As of the latest transaction made, First Foundation Advisors holds 3,463 shares of AMGN stock, worth $1.09 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,463

Previous 3,482 0.55%

Holding current value

$1.09 Million

Previous $990,000 9.29%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $4,992 - $6,066	-19 Reduced 0.55%	3,463 $1.08 Million
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $3,226 - $3,894	-12 Reduced 0.34%	3,482 $990,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $345,450 - $389,709	-1,351 Reduced 27.88%	3,494 $1.01 Million
Q3 2023 Nov 15, 2023	BUY	$218.65 - $271.46 $125,505 - $155,818	574 Added 13.44%	4,845 $1.3 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $190,700 - $225,499	-890 Reduced 17.24%	4,271 $948,000
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $80,155 - $97,696	355 Added 7.39%	5,161 $1.25 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $166,275 - $211,273	726 Added 17.79%	4,806 $1.26 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $2,020 - $2,278	9 Added 0.22%	4,080 $920,000
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $112,586 - $125,289	-488 Reduced 10.7%	4,071 $991,000
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $125,203 - $138,507	-571 Reduced 11.13%	4,559 $1.1 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $89,098 - $101,964	448 Added 9.57%	5,130 $1.15 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $89,365 - $104,702	-421 Reduced 8.25%	4,682 $996,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $277,025 - $307,340	-1,186 Reduced 18.86%	5,103 $1.24 Million
Q1 2021 May 18, 2021	SELL	$221.91 - $258.6 $8.22 Million - $9.58 Million	-37,061 Reduced 85.49%	6,289 $1.57 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $225,035 - $267,976	1,040 Added 2.46%	43,350 $9.97 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $8.22 Million - $9.14 Million	35,042 Added 482.14%	42,310 $10.8 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $39,562 - $48,548	200 Added 2.83%	7,268 $1.71 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $51,209 - $67,917	281 Added 4.14%	7,068 $1.43 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $458,455 - $589,273	2,423 Added 55.52%	6,787 $1.64 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $166,275 - $199,232	955 Added 28.01%	4,364 $845,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $68,180 - $79,922	409 Added 13.63%	3,409 $628,000
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $8,139 - $9,174	45 Added 1.52%	3,000 $570,000
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $37,820 - $44,149	-212 Reduced 6.69%	2,955 $575,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $218,827 - $246,699	-1,181 Reduced 27.16%	3,167 $656,000
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $54,796 - $61,548	-330 Reduced 7.05%	4,348 $803,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $73,532 - $85,932	434 Added 10.23%	4,678 $797,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $14,853 - $16,595	88 Added 2.12%	4,244 $738,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $83,645 - $95,500	500 Added 13.68%	4,156 $775,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,656	3,656 $630,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.

Account

First Foundation Advisors Amgen Inc Transaction History